BioNTech records loss of 190 mln euros in Q2 as covid vaccine demand wanes hawaiitelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hawaiitelegraph.com Daily Mail and Mail on Sunday newspapers.
BERLIN, Aug. 7 (Xinhua) German developer and manufacturer of active immunotherapies BioNTech on Monday posted a loss of 190 million euros (209 million U.S. dollars) in the second quarter of 2023 as demand for its COVID-19 vaccine waned.
BioNTech records loss of 190 mln euros in Q2 as covid vaccine demand wanes europesun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europesun.com Daily Mail and Mail on Sunday newspapers.